Detection of HPV DNA in Lymph Nodes in Early Stages Cervical Cancers

Czech version

Authors: J. Sláma ¹; M. Dražďáková ²; D. Fischerová ¹; J. Svárovský ¹; P. Freitag ¹; M. Zikán ¹; M. Janoušek ¹; I. Pinkavová ¹; D. Pavlišta ¹; N. Jančárková ¹; D. Cibula ¹
Authors‘ workplace: Gynekologicko-porodnická klinika VFN a 1. LF UK, Praha, přednosta prof. MUDr. A. Martan, DrSc. ¹; Ústav klinické biochemie a laboratorní diagnostiky VFN a 1. LF UK, Praha, přednosta prof. MUDr. T. Zima, DrSc ²
Published in: Ceska Gynekol 2008; 73(4): 217-221

Overview

Objective:
Review recent knowledge concerning significance of detection of DNA HPV in regional lymph nodes in cervical cancer patients.

Type of the study:
Literature review.

Setting:
Department of Obstetrics and Gyneacology, 1st Faculty of Medicine, Charles University and General Teaching Hospital, Prague.

Results:
Metastatic involvement of pelvic lymph nodes is the most important prognostic parameter in early stages cervical cancer. Still, almost 20% of patients with negative pelvic nodes experience recurrence. Detection of HPV DNA in lymph nodes might be a marker of occult metastatic involvement. However, published data are limited, mostly due to inconsistent methodology. Only 3 prospective studies evaluating HPV from fresh or frozen tissue were published till now, all other retrospective studies extracted HPV DNA from paraffin embedded samples. A few papers showed correlation between HPV DNA and metastatic involvement of pelvic lymph nodes. DNA HPV identification in histopatology-negative nodes was considered as a risk factor for recurrence. Presence of DNA HPV 18 in histopathology-negative pelvic nodes was described as a poor prognostic factor; however prognostic significance of individual genotype is still unclear.

Conclusion:
Detection of high risk HPV DNA in regional lymph nodes is a good candidate for prognostic parameter in early stages cervical cancers. The group of women with both absence of metastatic involvement and negative HPV DNA evaluation of regional lymph node should represent a cohort of patients with particularly good prognosis.

Key words:
HPV, lymph nodes, cervical cancer, prognostic factor.

Sources

1. Chan, PK., Yu, MM., Cheung, TH., et al. Detection and quantitation of human papillomavirus DNA in primary tumour and lymph nodes of patients with early stage cervical carcinoma. J Clin Virol, 2005, 33, p. 201–205.

2. Coutant, C., Barranger, E., Cortez, A., et al. Frequency and prognostic significance of HPV DNA in sentinel lymph nodes of patients with cervical cancer. Ann Oncol, 2007, 18, p. 1513-1517.

3. Czegledy, J., Josif, C., Forslund, O., et al. Detection of human papilloma virus DNA in lymph nodes extirpated at radical surgery for cervical cancer is not predictive of recurrence. J Med Virol, 1998, 54, p. 183–185.

4. Fülle, T., Csapo, Z., Mathe, M., et al. Prognostic significance of high-risk HPV status in advanced cervical cancers and pelvic lymph nodes. Gynecol Oncol, 2006, 100, p. 570–578.

5. Hernadi, Z., Szarka, K., Sapy, T., et al. The prognostic significance of HPV-16 genome status of the lymph nodes, the integration status and p53 genotype in HPV-16 positive cervical cancer: a long term follow up. BJOG, 2003, 110, p. 205–209.

6. Hording, U., Ravn, V., Knudsen, J., Visfeld, J. The use of polymerase chain reaction to detect metastatic cancer cells within lymph nodes in stage I cervical carcinoma. Int J Gynecol Pathol, 1995, 14, p. 339–343.

7. Kobayashi, Y., Yoshinouchi, Y., Tianqi, M., et al. Presence of human papilloma virus DNA in pelvic lymph nodes can predict unexpected recurrence of cervical cancer in patients with histologically negative lymph nodes. Clin Cancer Res, 1998, 4, p. 979–983.

8. Lee, YS., Rhim, CC., Lee, HN., et al. HPV status in sentinel nodes might be a prognostic factor in cervical cancer. Gynecol Oncol, 2007, 105, p. 351-¨357.

9. Lukaszuk, K., Liss, J., Gulczynski, J., et al. Predictive value of HPV DNA in lymph nodes in surgically treated cervical carcinoma patients - a prospective study. Gynecol Oncol, 2007, 104, p. 721-726.

10. Lukaszuk, K., Liss, J., Wozniak, I., et al. HPV and histological status of pelvic lymph node metastases in cervical cancer: a prospective study. J Clin Pathol, 2004, 57, p. 472–476.

11. Pilch, H., Gunzel, S., Schaffer, U., et al. Human papillomavirus (HPV) DNA in primary cervical cancer and in cancer free pelvic lymph nodes - Correlation with clinico-pathological parameters and prognostic significance. Zentralbl Gynacol, 2001, 123, p. 91–101.

12. Sapy, T., Hernandi, Z., Konya, Y., Lukacsko, L. Poor clinical outcome in early stage cervical cancer with human papillomavirus -18 positive lymph nodes. Eur J Obstet Gynecol Reprod Biol, 2000, 90, p. 93–95.